Amylyx Pharmaceuticals Inc (AMLX)
R&D to Revenue
0.00%
Fiscal year · Period ending:
AMLX R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
AMLX FY R&D/Revenue (834.43% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
AMLX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 119.1288% | |
| 33.6638% | |
| 420.3779% | |
| 0% | |
| 3,783.6923% | |
| 834.432% |